The Valley Desk

NCT00056381 · Interventional trial

Safety, Tolerance and Pharmacokinetics of Anidulafungin in Immunocompromised Children Ages 2-17

Overall registry status Completed

Phase 1 · Phase 2

Conditions Neutropenia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov